Skip to main content
TipRanks
Go Ultimate75% OFF

Cipher Pharmaceuticals (CPH) Stock Statistics & Valuation Metrics

94 Followers

Total Valuation

Cipher Pharmaceuticals has a market cap or net worth of CAD 360.13M. The enterprise value is CAD 333.36M.

Market Cap
CAD 360.13M
Enterprise Value
CAD 333.36M

Share Statistics

Cipher Pharmaceuticals has 25,415,071 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
25,415,071
Owned by Insiders
41.67%
Owned by Institutions
3.68%

Financial Efficiency

Cipher Pharmaceuticals’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 12.78%.

Return on Equity (ROE)
0.22
Return on Assets (ROA)
0.18
Return on Invested Capital (ROIC)
12.78%
Return on Capital Employed (ROCE)
0.13
Revenue Per Employee
10.27M
Profits Per Employee
5.56M
Employee Count
5
Asset Turnover
0.33
Inventory Turnover
2.15

Valuation Ratios

The current PE Ratio of Cipher Pharmaceuticals is 8.71. Cipher Pharmaceuticals’s PEG ratio is 0.06.

PE Ratio
8.71
PS Ratio
5.12
PB Ratio
1.84
Price to FCF
9.37
Price to Operating Cash Flow
9.32
PEG Ratio
0.06

Income Statement

In the last 12 months, Cipher Pharmaceuticals had revenue of 51.33M and earned 27.81M in profits. Earnings per share was 1.09.

Revenue
51.33M
Gross Profit
33.77M
Operating Income
16.80M
Pretax Income
17.46M
Net Income
27.81M
EBITDA
24.10M
Earnings Per Share (EPS)
1.09

Cash Flow

In the last 12 months, operating cash flow was 27.05M and capital expenditures -122,937, giving a free cash flow of 26.93M billion.

Operating Cash Flow
27.05M
Free Cash Flow
26.93M
Free Cash Flow per Share
1.06

Dividends & Yields

Cipher Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
10.67%
Earnings Yield
11.49%

Stock Price Statistics

Beta
1.07
52-Week Price Change
6.62%
50-Day Moving Average
13.77
200-Day Moving Average
15.80
Relative Strength Index (RSI)
61.77
Average Volume (3m)
27.47K

Important Dates

Cipher Pharmaceuticals upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Mar 18, 2027
Ex-Dividend Date
―

Financial Position

Cipher Pharmaceuticals as a current ratio of 1.12, with Debt / Equity ratio of 4.36%

Current Ratio
1.12
Quick Ratio
0.79
Debt to Market Cap
0.02
Net Debt to EBITDA
-0.08
Interest Coverage Ratio
14.17

Taxes

In the past 12 months, Cipher Pharmaceuticals has paid -10.34M in taxes.

Income Tax
-10.34M
Effective Tax Rate
-0.59

Enterprise Valuation

Cipher Pharmaceuticals EV to EBITDA ratio is 9.97, with an EV/FCF ratio of 9.05.

EV to Sales
4.94
EV to EBITDA
9.97
EV to Free Cash Flow
9.05
EV to Operating Cash Flow
9.01

Balance Sheet

Cipher Pharmaceuticals has CAD 9.10M in cash and marketable securities with CAD 366.40K in debt, giving a net cash position of CAD 8.73M billion.

Cash & Marketable Securities
CAD 9.10M
Total Debt
CAD 366.40K
Net Cash
CAD 8.73M
Net Cash Per Share
CAD 0.34
Tangible Book Value Per Share
CAD 1.98

Margins

Gross margin is 70.55%, with operating margin of 38.75%, and net profit margin of 58.81%.

Gross Margin
70.55%
Operating Margin
38.75%
Pretax Margin
35.22%
Net Profit Margin
58.81%
EBITDA Margin
49.59%
EBIT Margin
38.75%

Analyst Forecast

The average price target for Cipher Pharmaceuticals is CAD 20.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
CAD 20.00
Price Target Upside
41.14% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
-1.87%
EPS Growth Forecast
100.05%

Scores

Smart Score
7
AI Score
78